| Popis: |
Prifinium bromide is an anti-cholinergic drug, available commercially in various pharmaceutical formulations such as tablets, suppositories, syrups, and ampoules. The present available analytical methods are time-consuming and range from non-aqueous titration to UV-spectrophotometry to ion-pair visible spectrophotometry. The method reported here is a fast, reliable, and stability-indicating reversed phase HPLC for prifinium bromide in its various pharmaceutical formulations. The mobile phase was 0.03 M ammonium acetate in acetonitrile: water (65:35); the pH was adjusted to 4.0 with glacial acetic acid. The column utilized was (250 mm × 4.6 mm i.d.) Supelcosil LC-8-DB (5μ) and detection was carried at 254 nm. Benzophenone was used as internal standard. The assay was applied to commercial products and the results expressed in (% label claim ± RSD) are (99-58 ± 0.36), (100.50 ± 0.40), (99-95 ± 0.70), (99. 94 ± 0.29), (100.28 ± 0.52), and (99-99 ± 0.57) for six commercial formulations. The method was... |
